Acute Lymphoblastic Leukemia, High Risk
1 clinical trials · Condition
◉ Watch Acute Lymphoblastic Leukemia, High Risk
| Record | Firm | Date |
|---|---|---|
| Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies (NCT07366801) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-09-03 |
Track Acute Lymphoblastic Leukemia, High Risk automatically
Every clearance here is in the API, with alerts when new ones post.